Literature DB >> 30906749

Initial treatment combined with Prunella vulgaris reduced prednisolone consumption for patients with subacute thyroiditis.

Fuqiang Li1, Yijun Wu1, Liang Chen1, Liang Hu1, Xiaosun Liu1.   

Abstract

BACKGROUND: Subacute thyroiditis (SAT) is a self-limited disease commonly treated with prednisolone (PSL). The present study aimed to assess the effectiveness and safety of the new treatment protocol which consisted of PSL and Prunella vulgaris (PV) to reduce the dosage and incidence of side effects from PSL.
METHODS: Data regarding the patients with SAT treated at the First Affiliated Hospital, School of Medicine, Zhejiang University between September 2013 and May 2016 were retrospectively analyzed. Patients treated with PSL only or a combination of PSL and PV were divided into two groups.
RESULTS: In total, 87 patients were included. Patients treated with PSL and PV showed a similar remission rate to the patients who received only PSL. The recurrence rate (4.4% vs. 9.5%) and incidence of transient hypothyroidism (2.2% vs. 4.8%) were similar between the two groups (P=0.350 and P=0.517, respectively). Only two cases of a mild skin rash were recorded, and these were related to the use of PV.
CONCLUSIONS: The combination of low-dose PSL as a treatment choice for SAT was both effective and safe.

Entities:  

Keywords:  Prunella vulgaris (PV); Subacute thyroiditis (SAT); prednisolone; prognosis

Year:  2019        PMID: 30906749      PMCID: PMC6389583          DOI: 10.21037/atm.2019.01.07

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  11 in total

1.  Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris.

Authors:  S Y Ryu; M H Oak; S K Yoon; D I Cho; G S Yoo; T S Kim; K M Kim
Journal:  Planta Med       Date:  2000-05       Impact factor: 3.352

2.  Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.

Authors:  Rebecca S Bahn Chair; Henry B Burch; David S Cooper; Jeffrey R Garber; M Carol Greenlee; Irwin Klein; Peter Laurberg; I Ross McDougall; Victor M Montori; Scott A Rivkees; Douglas S Ross; Julie Ann Sosa; Marius N Stan
Journal:  Thyroid       Date:  2011-04-21       Impact factor: 6.568

Review 3.  Thyroiditis.

Authors:  Elizabeth N Pearce; Alan P Farwell; Lewis E Braverman
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

Review 4.  [The diagnosis and therapy of de Quervain's subacute thyroiditis].

Authors:  C Kujat; R Dyck; J Brederhoff; P Pfannenstiel
Journal:  Dtsch Med Wochenschr       Date:  1991-09-20       Impact factor: 0.628

Review 5.  Chinese herbal medicine for subacute thyroiditis: a systematic review of randomized controlled trials.

Authors:  Hui Luo; Meng Lü; Xiaohua Pei; Zhongyuan Xia
Journal:  J Tradit Chin Med       Date:  2014-06       Impact factor: 0.848

6.  Prevention of recurrence in acute thyoiditis following corticosteroid withdrawal.

Authors:  A G Vagenakis; C M Abreau; L E Braverman
Journal:  J Clin Endocrinol Metab       Date:  1970-12       Impact factor: 5.958

7.  Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone.

Authors:  T Mizukoshi; S Noguchi; T Murakami; T Futata; H Yamashita
Journal:  Intern Med       Date:  2001-04       Impact factor: 1.271

8.  Biological activities of Prunella vulgaris extract.

Authors:  Jitka Psotová; Milan Kolár; Jaromír Sousek; Zdenek Svagera; Jaroslav Vicar; Jitka Ulrichová
Journal:  Phytother Res       Date:  2003-11       Impact factor: 5.878

9.  Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study.

Authors:  Vahab Fatourechi; Jaroslaw P Aniszewski; Guiti Z Eghbali Fatourechi; Elizabeth J Atkinson; Steven J Jacobsen
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

10.  NF-κB-targeted anti-inflammatory activity of Prunella vulgaris var. lilacina in macrophages RAW 264.7.

Authors:  Yu-Jin Hwang; Eun-Ju Lee; Haeng-Ran Kim; Kyung-A Hwang
Journal:  Int J Mol Sci       Date:  2013-10-30       Impact factor: 5.923

View more
  7 in total

Review 1.  New Therapeutic Horizon of Graves' Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine.

Authors:  Qiongyao He; Hui Dong; Minmin Gong; Yujin Guo; Qingsong Xia; Jing Gong; Fuer Lu
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

2.  Mechanisms of Spica Prunellae against thyroid-associated Ophthalmopathy based on network pharmacology and molecular docking.

Authors:  Yuhan Zhang; Xianzhi Li; Congcong Guo; Jianjun Dong; Lin Liao
Journal:  BMC Complement Med Ther       Date:  2020-07-20

3.  Analysis of the Molecular Mechanisms of the Effects of Prunella vulgaris against Subacute Thyroiditis Based on Network Pharmacology.

Authors:  Xin Shen; Rui Yang; Jianpeng An; Xia Zhong
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-10       Impact factor: 2.629

4.  Risk Factors for Subacute Thyroiditis Recurrence: A Systematic Review and Meta-Analysis of Cohort Studies.

Authors:  Jing Zhang; Guoyong Ding; Jingru Li; Xiao Li; Lin Ding; Xiangyun Li; Shuxiang Yang; Fang Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

5.  Water-Extracted Prunella vulgaris Alleviates Endometriosis by Reducing Aerobic Glycolysis.

Authors:  Min Kyoung Cho; Ling Jin; Jung Ho Han; Jung-Suk Jin; Se-Yun Cheon; Su Shin; Sung-Jin Bae; Jang-Kyung Park; Ki-Tae Ha
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

Review 6.  Management of Subacute Thyroiditis - A Systematic Review of Current Treatment Protocols.

Authors:  Ishita Ray; Brandon D'Souza; Pallab Sarker; Pawan Agarwal
Journal:  Int J Gen Med       Date:  2022-08-06

Review 7.  Emerging therapeutic role of Prunella vulgaris in thyroid disease.

Authors:  Wen Zhang; Qimuge Wuhan; Meiri Na; Riba Hu; Qier Mu; Xilinqiqige Bao
Journal:  Chin Herb Med       Date:  2022-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.